Sign up now and fund within 24h to get free NKE, GPRO or DBX stock.T&Cs apply.
Redeem Now
Design Therapeautics, Inc.

Kickstart your portfolio with a U.S. stock on us

Sign up and fund a new Wall St account and get a full U.S. share.T&Cs apply

Claim now
Kickstart your portfolio with a U.S. stock on us

About DSGN

Design Therapeutics, Inc. is a biotechnology company. It is engaged in the research and development of GeneTACT molecules, which are small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its Friedreich ataxia (FA) program is focused on the development of a disease-modifying treatment. Its DT-216 is developed to overcome the FXN transcription impairment that causes FA. DT-216 is in Phase I clinical trial. It is also engaged in developing DT-216 to enable higher exposure and chronic administration for treatment of FA, known as DT-216P2, which uses the same drug substance, DT-216. Its FECD program is focused on the development of a potentially disease-modifying medical treatment for FECD, DT-168, which is in Phase I clinical trial. Its Huntington's Disease program is focused on the development of a potentially disease-modifying treatment for HD.

Market Capitalisation

$596.82M

Price-earnings ratio

-

Dividend yield

0.00%

Volume

281.94K

High today

$9.57

Low today

$8.96

Open price

$9.33

52-week high

$17.25

52-week low

$7.81

Ready to start your investing journey with Stake?

Open an account
Buying DSGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Design Therapeautics, Inc. in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in DSGN

The ticker symbol for Design Therapeautics, Inc. is DSGN.

One share of DSGN is valued at $9.02 as of 21 November 2026.

As of 21 November 2026 Design Therapeautics, Inc. has a market cap of $596.82M.

The Design Therapeautics, Inc. 52-week high stock price is $17.25.

The Design Therapeautics, Inc. 52-week low stock price is $7.81.

Yes, the Stake investing platform allows you to buy DSGN shares and over 11,000 more stocks and ETFs on Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Stake app

Invest in DSGN on Stake

  • Buy DSGN from US$3 brokerage
  • Invest in 11,000+ U.S. stocks and ETFs
  • Own a slice of DSGN from only US$10 with fractional shares
Get started

Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.

Explore Stake


Bringing Wall St to NZ since 2020

Sydney, Australia


Get the app

Scan QR code to download the app

Stakeshop Pty Ltd is registered as an overseas company in New Zealand (NZBN: 9429047452152), and is registered as a Financial Service Provider under the Financial Service Providers (Registration and Dispute Resolution) Act 2008 (No. FSP774414). We hold a full licence issued by the Financial Markets Authority to provide a financial advice service under the Financial Markets Conduct Act 2013. However, the content on this website has not been prepared to take into account any of your individual objectives, financial situation or needs. To the extent you require further information about the relevant New Zealand legislation that may apply, or require specific advice, please contact your legal and/or financial adviser (as appropriate). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Terms & Conditions, Privacy Policy, Financial Advice Disclosure and Disclaimers before deciding to use or invest on Stake. By using the Stake website or service in any way, you agree to our Privacy Policy and Terms & Conditions All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake is a registered trademark under class 36 (New Zealand).

Copyright © 2026 Stake. All rights reserved.